Pharmhouse Corp (PHSE)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Pharmhouse Corp (PHSE) is down 55.6% since the beginning of the year. At $0 per share, PHSE is trading 75.8% below its 52-week high of $0.

Pharmhouse Corp (PHSE) has returned -55.60% so far this year and 222.39% over the past 12 months.

Based on dividend-adjusted daily data since May 15, 2025, PHSE's average daily return is +1.51%, while the average monthly return is +20.19%. At this rate, an investment would double in approximately 0.3 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jul 2025 with a return of +221.4%, while the worst month was May 2026 at -47.4%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 3 months.

On a daily basis, PHSE closed higher 42% of trading days. The best single day was May 23, 2025 with a return of +147.9%, while the worst single day was May 22, 2025 at -58.3%.

Pharmhouse Corp has an annualized alpha of 3145.27%, beta of 1.30, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 15, 2025.

• This stock tended to rise when S&P 500 Index fell (downside capture of -2292.82%), but participation in market rallies was also limited (-47.00%) - a profile typical of counter-cyclical assets.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PHSE ranks 80 for risk / return — better than 80% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Pharmhouse Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Pharmhouse Corp was 84.55%, occurring on May 26, 2026. The portfolio has not yet recovered.

The current Pharmhouse Corp drawdown is 75.82%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Pharmhouse Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Pharmhouse Corp is priced in the market compared to other companies in the Entertainment industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.